In the shadow of the cough syrup controversy in the country last year, the segment is showing a ‘cautious’ shift in sales towards products from well-established companies, say industry watchers.

MUMBAI, March 14 (Reuters) - An Indian court on Monday granted U.S. pharmaceuticals giant Pfizer Inc's India unit a stay on a government ban on its popular cough syrup Corex, local television channels ...

MUMBAI/NEW DELHI, March 14 (Reuters) - An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular ...

In Pfizer Products Inc v Singh Tyagi, the Delhi High Court has issued an injunction preventing the defendants from manufacturing and selling cough syrup under the mark OREX, and awarded Rs100,000 in ...